Abstract

THE PURPOSE of this paper is to report and evaluate our experience with the intravenous use of procaine hydrochloride ( p -aminobenzol-diethylaminoethanol hydrochloride) as a therapeutic measure to combat pruritus and facilitate healing in a group of common pruritic dermatoses. For a long time procaine hydrochloride had been used only as a local anesthetic, although August Bier, 1 in 1908, introduced a method for its intravenous use. Intravenous procaine therapy, like many other medical procedures, was introduced with a wave of enthusiasm, only to be followed by a wave of skepticism and censure which ultimately condemned its use as a dangerous procedure, temporarily discarding it as a method of therapy. After World War II, its general anesthetic properties became better known, which caused a renewed interest in its use. There soon followed published reports of its use in the treatment of pruritus of jaundice, contact dermatitis, serum sickness, exfoliative dermatitis, pruritus ani, drug eruptions, and other dermatologic manifestations. 2

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.